Substantial testing has been completed and more will be beginning, says Nuvilex, Inc. (OTCQB: NVLX), using its patented encapsulation technology with live stem cells. The process, being carried out in Austria’s laboratories in Singapore, could help develop a vast quantity of live virgin stem cells. The cells can be used in many applications and...